These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

923 related articles for article (PubMed ID: 9200008)

  • 21. Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women.
    Shan PF; Wu XP; Zhang H; Luo XH; Cao XZ; Xie H; Liu SP; Pi YZ; Fang TY; Liu H; Chen ZH; Zhong N; Liao EY
    Clin Chim Acta; 2006 Apr; 366(1-2):233-8. PubMed ID: 16330011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationships between circulating matrix metalloproteinase-1, -2 and metalloproteinase-1 levels and bone biochemical markers and bone mineral density in Chinese postmenopausal women].
    Guo LJ; Luo XH; Wu XP; Xie H; Zhou HD; Zhang H; Cao XZ; Liao EY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):734-7. PubMed ID: 15949377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight.
    Viapiana O; Gatti D; Dalle Grave R; Todesco T; Rossini M; Braga V; Idolazzi L; Fracassi E; Adami S
    Bone; 2007 Apr; 40(4):1073-7. PubMed ID: 17240212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
    Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L
    J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical markers of bone metabolism and prediction of fracture in elderly women.
    Gerdhem P; Ivaska KK; Alatalo SL; Halleen JM; Hellman J; Isaksson A; Pettersson K; Väänänen HK; Akesson K; Obrant KJ
    J Bone Miner Res; 2004 Mar; 19(3):386-93. PubMed ID: 15040826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy.
    Rogers A; Glover SJ; Eastell R
    Bone; 2009 Dec; 45(6):1044-52. PubMed ID: 19665601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
    Garnero P; Delmas PD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biochemical markers of age-related changes in bones turnover and bone mineral density in healthy Chinese men].
    Jiang YX; Tang SY; Wu XP; Yang LF; Liao EY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):53-6. PubMed ID: 18245905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
    Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures.
    Bauer DC; Sklarin PM; Stone KL; Black DM; Nevitt MC; Ensrud KE; Arnaud CD; Genant HK; Garnero P; Delmas PD; Lawaetz H; Cummings SR
    J Bone Miner Res; 1999 Aug; 14(8):1404-10. PubMed ID: 10457273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis.
    Jiang LS; Zhang ZM; Jiang SD; Chen WH; Dai LY
    J Bone Miner Res; 2008 Apr; 23(4):475-83. PubMed ID: 18052758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in bone mass and bone turnover following ankle fracture.
    Ingle BM; Hay SM; Bottjer HM; Eastell R
    Osteoporos Int; 1999; 10(5):408-15. PubMed ID: 10591839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy.
    Fink E; Cormier C; Steinmetz P; Kindermans C; Le Bouc Y; Souberbielle JC
    Osteoporos Int; 2000; 11(4):295-303. PubMed ID: 10928218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response relationships between energy availability and bone turnover in young exercising women.
    Ihle R; Loucks AB
    J Bone Miner Res; 2004 Aug; 19(8):1231-40. PubMed ID: 15231009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.